An Efficacy and Safety Study of Palovarotene for the Treatment of MO - Global
Retour

An Efficacy and Safety Study of Palovarotene for the Treatment of MO

- 05 Septembre 2024 - 1  mn de lecture

This is a randomized, double-blind, placebo-controlled study comparing the safety and efficacy of 2 dosage regimens of palovarotene versus placebo in preventing disease progression in pediatric subjects with multiple osteochondromas (MO).

En rapport Clinical Trials

Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
05 Septembre 2024 1  mn de lecture

Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
05 Septembre 2024 1  mn de lecture

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
05 Septembre 2024 1  mn de lecture

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
05 Septembre 2024 1  mn de lecture

Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
05 Septembre 2024 1  mn de lecture

Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome
05 Septembre 2024 1  mn de lecture

Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
05 Septembre 2024 1  mn de lecture

Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
05 Septembre 2024 1  mn de lecture

Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
05 Septembre 2024 1  mn de lecture

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction
05 Septembre 2024 1  mn de lecture

Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction